GENE EDITING SOLUTIONS

Delivering the Next Evolution of Healthcare

Recombinetics is a recognized leader in animal gene-editing and associated applied technologies for biomedical research, regenerative medicine and animal agriculture.

We leverage our proprietary gene-editing platform to commercialize and deploy technologies through three subsidiaries that pivotally impact human health and longevity and add value to farm animals.

double helix

FACING THE FACTS

113,000

people are currently on the U.S. transplant list—83% are waiting for a kidney
human disease research models are currently based on

Mice.

1.5 Billion

smallholders raising unproductive animals
double helix
our work

Groundbreaking
Technology for
Life-Changing
Solutions

Recombinetics has the most experienced and reliable animal gene-editing team on the planet developing solutions through three customer-facing subsidiaries focused on three key areas:

regenerative medicine

Developing
Transplantable
Cells, Tissues and
Organs to Save Lives

We enable the most precise
possible resolution to human
illness through the ability to
provide patients with tissue and organ transplantation created using their own cells.

Regenevida logo
Learn More
pre-clinical research

Delivering Better
Models to Understand
Human Disease

We help pre-clinical researchers study and evaluate the efficacies of therapeutics through precise pig models of life-threatening human conditions such as heart disease, neurodegenerative diseases, diabetes and cancer.

Learn More
precision breeding

Producing Healthier, Happier Animals and
More Sustainable
Farming

We use state-of-the-art breeding methods to precisely deliver traits that improve the health, welfare and sustainability of food animals to feed a hungry world while protecting the environment.

Acceligen logo
Learn More
notable news

Mayo Clinic Collaboration

Recombinetics has joined forces with the Mayo Clinic in a multi-project, collaborative research and development agreement to advance capabilities to bioengineer human stem cells within swine models. The collaboration is focused on providing better health outcomes for patients by delaying the need for a transplant and reducing other complications including rejection and related cancers.

double helix

Your investment can help us change the world.

Reach out today for information on how you can make a difference.